Sharon McGee Profile
Sharon McGee

@smcgee_md

Followers
93
Following
25
Statuses
21

Medical Oncology Fellow. Interests in Breast Cancer & OncoFertility.

Ottawa, Ontario
Joined October 2016
Don't wanna be here? Send us removal request.
@smcgee_md
Sharon McGee
7 years
RT @NEJM: Original Article: Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer (SOFT/TEXT) Edito…
0
18
0
@smcgee_md
Sharon McGee
7 years
RT @cancermd: SOFT/TEXT trial update: Addition of Ovarian Function Suppression leads to improment in Distant Recurrence Free Survival for p…
0
6
0
@smcgee_md
Sharon McGee
7 years
Progress with a Price - excellent session on the search for breast cancer patients for whom less is more #ASCO2018
1
0
2
@smcgee_md
Sharon McGee
7 years
Delighted to speak about the importance of funding breast cancer research at the Mother’s Day Walk today #canadianbreastcancersociety
Tweet media one
1
0
2
@smcgee_md
Sharon McGee
7 years
0
0
0
@smcgee_md
Sharon McGee
7 years
Supratherapeutic INR #MandMRounds
1
0
0
@smcgee_md
Sharon McGee
7 years
@Garth_Nicholas1 Sadly I do not think fertility preservation has been seen as a priority in recent times. And I think the concerns regarding safety for ER+ patients particularly really curbed interest in ovarian preservation strategies.
0
0
1
@smcgee_md
Sharon McGee
7 years
RT @cancermd: ABCSG-16 : No improvement with 5 years of AI vs. 2 years of AI after initial 5 years of endocrine Tx. #SABCS17
0
12
0
@smcgee_md
Sharon McGee
7 years
RT @cancermd: TEXT and SOFT combined analysis (med f/up 9 yr): Maintained benefit for OFS and Exemestane in DFS for pts undergoing chemo #S
0
2
0
@smcgee_md
Sharon McGee
7 years
GnRHa May Protect Ovarian Function, Preserve Fertility in Premenopausal Women With Early-Stage Breast Cancer via @onclive #Oncofertility #breastcancer #sabcs17
1
1
2
@smcgee_md
Sharon McGee
7 years
RT @cancermd: Monaleesa 7 results by @DrDebuTripathy - first line Ribociclib in pre/peri-menopausal HR+ve MBC. Improved PFS (HR 0.55) #SABC
0
13
0
@smcgee_md
Sharon McGee
7 years
RT @cancermd: Phase II trial of Sacituzumab in TNBC - RR 34% ; Duration of response: 7.6m; PFS 5.5m. Impressive efficacy in heavily pre-Tx…
0
4
0
@smcgee_md
Sharon McGee
7 years
RT @cancermd: Dr. Gray sharing data on chemotherapy schedule impact on breast cancer outcome - overall improved outcome with dose dense app…
0
14
0
@smcgee_md
Sharon McGee
7 years
Academic Half Day - The Hallmarks of Cancer: Next Generation @OttawaMedOnc
0
1
2
@smcgee_md
Sharon McGee
7 years
RT @emergmedottawa: The New and Old of Cancer Emergencies - Dr. Rory Connolly reviews the most common complications of cancer treatments in…
0
6
0
@smcgee_md
Sharon McGee
7 years
RT @fertilefutureca: Among teenage males undergoing cancer treatment, having children was ranked above making money, owning a home, faith,…
0
3
0
@smcgee_md
Sharon McGee
7 years
Thanks to the @oncofertility consortium for awarding me a scholarship to attend their annual meeting for the first time - I leave inspired to continue the amazing work! #oncofertility #breastcancer
Tweet media one
Tweet media two
Tweet media three
0
0
5
@smcgee_md
Sharon McGee
8 years
Follow up to MBTI personality test for those interested! @OttawaMedOnc
0
2
3
@smcgee_md
Sharon McGee
8 years
0
0
0
@smcgee_md
Sharon McGee
8 years
Thanks to all for the great discussion on avastin complications & TPN in advanced cancer at M&M today! @OttawaMedOnc
1
0
1